Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Boehringer Ingelheim discloses BTK and IL-6 production inhibitors

Aug. 3, 2017

RSV inhibitors identified by Enanta Pharmaceuticals

Aug. 3, 2017

Bristol-Myers Squibb presents ROCK2 inhibitors

Aug. 3, 2017

U.S. researchers patent EAAT2 activators

Aug. 3, 2017

Rockefeller University divulges FXIIa inhibitors

Aug. 2, 2017

Soluble guanylate cyclase activators presented by Bayer

Aug. 2, 2017

Teva presents laquinimod prodrugs for multiple sclerosis

Aug. 2, 2017

Arcus Biosciences divulges CD73 inhibitors

Aug. 2, 2017

Celgene identifies antiproliferative compounds for AML

Aug. 2, 2017

French researchers patent compounds for treating cancer

Aug. 2, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...